ecrin-mdr-crcClinical2016Patient with metastatic colorectal cancerColorectal cancer Duke's DPatient With Metastatic Colorectal CancerColorectal Cancer Duke's DInterventionalhttps://newmdr.ecrin.org/Study/2535860Denmark9RegorafenibirinotecanbevacizumabpanitumomabECRIN MDRCompletedfalseA randomized phase II study between regorafenib and continuing biologic treatment to multi treated patients with colorectal cancer.Primary objectives: Overall survival between the two groups2016-09-1525358602016-002222-37